MISSION: END PREVENTABLE BLINDNESS

DEWS II - Update on Dry Eye Syndrome Treatments

Updated Dry Eye Treatment According to DEWS II

Trace to mild dry eye syndrome

The treatment and modifications in step 1 should be done by ALL dry eye syndrome sufferers.   This is the basis to treatment for all disease.  Remember that a disease is your body's way of telling you that something YOU are doing is wrong!

Mild to moderate dry eye syndrome

    • Changing to a non-preserved topical lubrication
    • Using tea tree oil if Demodex is present
    • Tear conservation, such as punctal occlusion
    • Moisture chamber spectacles or goggles
    • Overnight treatments such as ointments
    • With meibomian gland dysfunction, in-office treatments, such as LipiFlow® or intense pulsed light therapy
    • Topical antibiotics or antibiotic/steroid combinations
    • Limited-duration topical steroids
    • Topical secretagogues
    • Topical anti-inflammatory medications such as cyclosporine (Restasis®)
    • Topical LFA-1 antagonists such as lifitegrast (Xiidra®)
    • Oral macrolide or tetracycline antibiotics

    Moderate to severe dry eye syndrome

        Severe dry eye syndrome

              Related Posts

              Comments

              Amy Gallant Sullivan, Executive Director TFOS on August 09 2017 at 09:59PM

              Dr. Zigler – Thank you for reviewing the TFOS DEWS II report. TFOS will also be publishing an executive summary of this report as well as a handout for clinicians. . . and a patient version. For more information about TFOS DEWS II and our other reports, on meibomian gland dysfunction, contact lens discomfort, etc. please visit our website: http://tearfilm.org/

              Leave a comment

              Comments have to be approved before showing up
              Sale

              Unavailable

              Sold Out